| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 322.96B | 316.40B | 312.36B | 275.78B | 223.62B | 216.93B |
| Gross Profit | 48.65B | 43.54B | 42.92B | 36.14B | 33.47B | 30.17B |
| EBITDA | 26.01B | 22.59B | 22.59B | 14.52B | 10.31B | 14.12B |
| Net Income | 10.36B | 6.12B | 5.30B | 1.31B | -5.18B | 517.00M |
Balance Sheet | ||||||
| Total Assets | 346.77B | 332.10B | 338.63B | 356.23B | 329.55B | 315.19B |
| Cash, Cash Equivalents and Short-Term Investments | 50.37B | 35.30B | 33.26B | 30.04B | 24.80B | 41.65B |
| Total Debt | 38.32B | 37.22B | 32.62B | 84.30B | 74.09B | 73.19B |
| Total Liabilities | 115.27B | 111.86B | 109.57B | 149.85B | 134.68B | 128.66B |
| Stockholders Equity | 229.35B | 216.69B | 221.54B | 199.54B | 186.26B | 179.22B |
Cash Flow | ||||||
| Free Cash Flow | 16.88B | -1.85B | 13.15B | -27.61B | -12.91B | 525.00M |
| Operating Cash Flow | 30.16B | 15.27B | 24.64B | -18.06B | -5.44B | 10.60B |
| Investing Cash Flow | -7.79B | -8.31B | 37.93B | 19.71B | -7.52B | -13.01B |
| Financing Cash Flow | -9.93B | -4.75B | -59.58B | 2.03B | -5.50B | 4.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥259.75B | 8.29 | ― | 3.36% | 1.36% | 139.77% | |
76 Outperform | ¥716.21B | 14.05 | 7.20% | 2.41% | -0.73% | 88.36% | |
75 Outperform | ¥494.22B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
74 Outperform | ¥148.77B | 10.91 | ― | 2.93% | 1.77% | 117.03% | |
67 Neutral | ¥5.29T | 10.20 | 6.98% | 2.98% | 2.41% | 11.03% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥213.78B | 16.01 | ― | 4.77% | -3.71% | -51.81% |